In part 1 of this Exclusive Interview, Lisa Latts talks with Diabetes in Control Publisher Steve Freed about the work done in partnership with the ADA regarding findings among patients with diabetes and their use of medications.
Lisa Latts MD, MSPH, MBA, FACP is Deputy Chief Health Officer for IBM Watson Health.
Transcript of this video segment:
Freed: This is Steve Freed with Diabetes in Control. And we’re here with a special guest at the American Diabetes Association, 78th Scientific Sessions, Lisa Latts, who’s presenting I believe. And maybe you can start off with tell us a little bit about yourself.
Latts: Terrific. So, good morning. I am Dr. Lisa Latts. I’m Deputy Health Officer with IBM Watson Health. Internist by training, also have some specialty training in high risk pregnancy.
Freed: And what is the title of your presentation?
Latts: So, I spoke yesterday and what I presented was some analytic work that we had done in our partnership with the American Diabetes Association. IBM Watson Health has a partnership that we announced two years ago actually at this meeting with the American Diabetes Association. And so, among other work that we’re doing, I presented a paper that we had submitted yesterday looking at compliance in patients with diabetes who are on diabetes medication. So, we looked at individuals who were diagnosed with diabetes, who as far as we could tell within the year prior had not been diagnosed with diabetes or treated with diabetes meds. They were started on the med and then we looked at how long they took their medicine. And what we found is that among those individuals who were newly diagnosed with diabetes, 58%, six in ten, were not taking their medicine one year later